Mitsubishi UFJ Asset Management
ADVM

Mitsubishi UFJ Asset Management’s Adverum Biotechnologies ADVM Stock Holding History

Mitsubishi UFJ Asset Management’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-8,829
Closed -$192K – 1136
2021
Q3 		$192K Buy
8,829
+261
+3% +$6.66K ﹤0.01% 1072
2021
Q2 		$300K Buy
8,568
+5,679
+197% +$306K ﹤0.01% 1038
2021
Q1 		$285K Buy
2,889
+911
+46% +$109K ﹤0.01% 957
2020
Q4 		$214K Buy
1,978
+1,017
+106% +$126K ﹤0.01% 945
2020
Q3 		$99K Sell
961
-6
-0.6% -$899 ﹤0.01% 961
2020
Q2 		$202K Sell
967
-854
-47% -$151K ﹤0.01% 892
2020
Q1 		$178K Buy
1,821
+341
+23% +$39.8K ﹤0.01% 864
2019
Q4 		$172K Sell
1,480
-38
-3% -$3.35K ﹤0.01% 894
2019
Q3 		$83K Buy
1,518
+245
+19% +$27.6K ﹤0.01% 920
2019
Q2 		$151K Buy
+1,273
New +$105K ﹤0.01% 862
2018
Q4 		– Sell
-2,328
Closed -$141K – 918
2018
Q3 		$141K Buy
+2,328
New +$131K ﹤0.01% 815

Other funds holding ADVM

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
SFI
Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Mitsubishi UFJ Asset Management's ADVM Position: Q4 2021 in Review

Mitsubishi UFJ Asset Management sold out of Adverum Biotechnologies (ADVM) in Q4 2021, closing a stake of 8,829 shares — an estimated $192K sold.

Mitsubishi UFJ Asset Management first reported a position in ADVM in Q3 2018 and held it in 11 quarters. The position peaked at $300K in Q2 2021. 98 funds tracked by Wall St. Rank hold ADVM as of Q4 2021.

  • Mitsubishi UFJ Asset Management reported no remaining Adverum Biotechnologies position as of Q4 2021 after selling out during the quarter.
  • Mitsubishi UFJ Asset Management sold 8,829 Adverum Biotechnologies shares in Q4 2021, an estimated $192K.
  • Mitsubishi UFJ Asset Management first reported a position in Adverum Biotechnologies in Q3 2018 and held it in 11 quarters.
  • Mitsubishi UFJ Asset Management's Adverum Biotechnologies position peaked at $300K in Q2 2021.
  • 98 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q4 2021.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q4 2021, filed 7 Feb 2022.